This bill expands the list of vaccines available through Maine's Universal Immunization Program by requiring the state board to include vaccines recommended by the Northeast Public Health Collaborative alongside those recommended by federal health authorities. It allows the program to request state funding to cover costs for children who qualify for vaccines under the federal Vaccines for Children Program when federal funds are insufficient, provided the vaccines align with state or regional health guidelines. Additionally, the bill grants licensed pharmacists immunity from negligence lawsuits if they administer vaccines that follow state or regional recommendations, even when those vaccines fall outside federal guidelines. These changes directly affect Maine's vaccine distribution system, healthcare providers, and families seeking immunizations for their children.
This bill requires health insurance plans in Maine to cover blood testing for perfluoroalkyl and polyfluoroalkyl substances (PFAS) when a healthcare provider deems it medically necessary based on guidelines from the National Academies of Sciences, Engineering, and Medicine. It prohibits insurers from charging deductibles, copays, or coinsurance for these tests. The requirement applies to all health insurance plans issued or renewed in Maine on or after January 1, 2026. The bill states this coverage does not expand the state's essential health benefits under federal law, as it aligns with existing coverage for outpatient lab services.
This resolve authorizes the final adoption of specific regulatory provisions concerning the prescriptive authorities and collaborative relationships for naturopathic doctors in Maine. The Department of Professional and Financial Regulation submitted these rules to the legislature after the standard filing deadline, which required a special legislative action to approve them. By passing this measure, the state legislature grants the necessary approval for these professional practice standards to take effect immediately.
This bill expands vaccine access in Maine by allowing licensed pharmacists to prescribe, dispense, and administer FDA-approved vaccines without requiring a doctor's prescription for eligible patients. It requires health insurance plans and the MaineCare program to cover all vaccines without deductibles, copayments, or other out-of-pocket costs, including coverage for off-label vaccine use. Pharmacists can administer influenza vaccines to people aged 3 and older, and other CDC-recommended vaccines to adults 18 and older, with additional authority for COVID-19 vaccines to those aged 3 and older. The legislation also clarifies legal definitions for off-label use and medically accepted indications to support these expanded prescribing and administration powers.
This bill amends Maine's optometry practice laws to clarify the scope of services optometrists can provide. It explicitly permits optometrists to prescribe hydrocodone combination products and other controlled substances (such as schedule III-V drugs) for eye conditions, while listing specific procedures excluded from optometry practice (e.g., corneal transplants, retinal surgery, and surgeries requiring general anesthesia). The bill also requires optometrists to meet board-established credentialing standards before performing any ophthalmic surgery or laser procedures. These changes directly affect Maine optometrists by defining their prescribing authority and procedural boundaries.
This Maine bill requires hospitals to submit a formal notice to the state department at least 120 days before closing labor and delivery units or changing the level of maternity and newborn care services. The notification must include the effective date, reasons for the change, contact information, and details on how the hospital will handle emergency obstetric care. Hospitals must also document their efforts to notify surrounding facilities within 50 miles, local emergency services, affected patients, and the general public. These provisions are designed to ensure transparency and allow communities adequate time to prepare for changes in essential healthcare services.
This bill allows physician associates to work as the main healthcare providers in clinics that do not have a doctor on staff, removing the current requirement for them to have a formal practice agreement with an active physician. It also changes consultation rules by making it optional for physician associates to consult with physicians and removes the mandate that a physician must be available at all times for consultation. These changes aim to address shortages of medical providers, particularly in rural areas, by increasing the number of physician associates who can practice primary care. The legislation applies to physician associates, healthcare facilities, and medical practices across Maine.
This bill amends Maine's insurance code to explicitly include the MaineCare program as a "carrier" for prescription drug benefit purposes. The change clarifies that MaineCare, which provides health coverage to low-income residents, is treated similarly to private insurance carriers under state insurance regulations. By adding MaineCare to the definition of carrier, the legislation ensures the program falls under existing insurance code provisions governing prescription drug benefits. This adjustment affects how MaineCare is classified within the state's insurance framework without altering the program's core eligibility or funding structure.
LD 2004 modifies Maine's existing Fund To Address Food Insecurity and Provide Nutrition Incentives to better support local programs. It allows the fund to match private/public contributions up to $50,000 annually, prioritizing Maine-based organizations with experience helping low-income residents use federal food assistance (like SNAP) to buy locally grown fruits and vegetables. The bill requires organizations applying for funds to demonstrate how they will leverage the money or have a history of promoting local food access. It also mandates regular reporting and audits to ensure funds are used appropriately for nutrition incentive programs.
LD 697 directs Maine's Prescription Drug Affordability Board to set annual spending targets for prescription drugs purchased by state and local government health plans (excluding MaineCare), using a formula based on a 10-year average of medical care costs plus inflation, minus savings. The board must assess cost-reduction strategies, including reference-based pricing - which aligns drug prices with those in other regions - and establish a 12-member advisory council with representatives from state agencies, labor unions, and consumer groups to advise on setting targets and methods. The board will also identify public payors (state, county, and municipal health plans) likely to exceed the spending targets.